Patent · US Active

HPPD variants and methods of use

US10876130B2 · kind B2 · utility

0Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2015
Grant dateDec 29, 2020
Priority date
Expiry dateMar 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y113/11027
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

In the present invention, HPPD enzymes and plants containing them showing a full tolerance against several classes of HPPD-inhibitors are described. A set of HPPD enzymes have been designed which have either no or only a significantly reduced affinity to HPPD inhibitors and, at the same time, the rate of dissociation of the HPPD inhibitors of the enzyme is increased to such an extent that the HPPD inhibitors no longer act as slow-binding or slow, tight-binding inhibitors but, instead of this, have become fully reversible inhibitors. In particular, isolated polynucleotides encoding HPPD inhibitor tolerance polypeptides are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.